Literature DB >> 10393357

Primary effusional lymphoma: A new non-Hodgkin s lymphoma entity.

A Matolcsy1.   

Abstract

A distinct non-Hodgkin s lymphoma (NHL) entity that grow in the body cavities as lymphomatous effusions in the absence of clinically identifiable tumor masses has been defined as primary effusional lymphoma (PEL). This lymphoma characterized by distinetive morphology, immunophenotype, genotype and association with Kaposi s sarcoma-associated herpesvirus (KHSV)/human herpesvirus-8 (HHV-8) infection. In this minireview, the clinico-pathological and biological characteristics of PELs are summarized.

Entities:  

Mesh：

Year:  1999        PMID： 10393357     DOI： 10.1053/paor.1999.0203

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN： 1219-4956            Impact factor:   3.201


  18 in total

1.  Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus.

Authors:  R G Nador; E Cesarman; A Chadburn; D B Dawson; M Q Ansari; J Sald; D M Knowles
Journal:  Blood       Date:  1996-07-15       Impact factor: 22.113

2.  Genetic characterization of HHV-8/KSHV-positive primary effusion lymphoma reveals frequent mutations of BCL6: implications for disease pathogenesis and histogenesis.

Authors:  G Gaidano; D Capello; A M Cilia; A Gloghini; T Perin; S Quattrone; A Migliazza; F Lo Coco; G Saglio; V Ascoli; A Carbone
Journal:  Genes Chromosomes Cancer       Date:  1999-01       Impact factor: 5.006

3.  Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma.

Authors:  E Cesarman; R G Nador; F Bai; R A Bohenzky; J J Russo; P S Moore; Y Chang; D M Knowles
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

4.  Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients.

Authors:  J A Ambroziak; D J Blackbourn; B G Herndier; R G Glogau; J H Gullett; A R McDonald; E T Lennette; J A Levy
Journal:  Science       Date:  1995-04-28       Impact factor: 47.728

5.  Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells.

Authors:  H Asou; J W Said; R Yang; R Munker; D J Park; N Kamada; H P Koeffler
Journal:  Blood       Date:  1998-04-01       Impact factor: 22.113

6.  Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice.

Authors:  J B Wilson; J L Bell; A J Levine
Journal:  EMBO J       Date:  1996-06-17       Impact factor: 11.598

7.  Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus.

Authors:  D M Knowles; G Inghirami; A Ubriaco; R Dalla-Favera
Journal:  Blood       Date:  1989-02-15       Impact factor: 22.113

8.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Authors:  E Cesarman; Y Chang; P S Moore; J W Said; D M Knowles
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

9.  Kaposi's sarcoma-associated herpesvirus DNA sequences in AIDS-related and AIDS-unrelated lymphomatous effusions.

Authors:  A Carbone; A Gloghini; E Vaccher; V Zagonel; C Pastore; P Dalla Palma; F Branz; G Saglio; R Volpe; U Tirelli; G Gaidano
Journal:  Br J Haematol       Date:  1996-09       Impact factor: 6.998

10.  Diagnosis of malignant lymphoma in effusions from patients with AIDS by gene rearrangement.

Authors:  A E Walts; I P Shintaku; J W Said
Journal:  Am J Clin Pathol       Date:  1990-08       Impact factor: 2.493
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.